Showing results (11-20 of 56) with videos related to
Sort By:
Pageof 6
Research and Practice in Thrombosis and Haemostasis|October 12, 2020
Risk of venous thromboembolism in patients with COVID-19: A systematic review and meta-analysisStephan Nopp, Florian Moik, Bernd Jilma, et al.Research and Practice in Thrombosis and Haemostasis|June 18, 2020
Direct oral anticoagulants compared to low-molecular-weight heparin for the treatment of cancer-associated thrombosis: Updated systematic review and meta-analysis of randomized controlled trialsFlorian Moik, Florian Posch, Christoph Zielinski, et al.Cancers|January 25, 2025
Prevention and Treatment of Venous Thromboembolism Associated with Amivantamab-Based Therapies in Patients with Lung Cancer-Provisional Clinical Opinion Based on Existing Clinical Practice GuidelinesFlorian Moik, Gudrun Absenger, Robert Wurm, et al.Cancers|June 24, 2020
Systemic Inflammation and Activation of Haemostasis Predict Poor Prognosis and Response to Chemotherapy in Patients with Advanced Lung CancerFlorian Moik, Sabine Zöchbauer-Müller, Florian Posch, et al.Blood Advances|April 13, 2022
ABO blood group type and risk of venous thromboembolism in patients with cancerCornelia Englisch, Florian Moik, Stephan Nopp, et al.Journal of Thrombosis and Haemostasis : JTH|September 22, 2023
Pharmacokinetic-guided versus standard prophylaxis in hemophilia: a systematic review and meta-analysisDaniel Kraemmer, Oliver Königsbrügge, Florian Moik, et al.Journal of Thrombosis and Haemostasis : JTH|November 24, 2021
Extended anticoagulation treatment for cancer-associated thrombosis-Rates of recurrence and bleeding beyond 6 months: A systematic reviewFlorian Moik, Meaghan Colling, Isabelle Mahé, et al.Thrombosis Research|January 17, 2020
Haemostatic biomarkers for prognosis and prediction of therapy response in patients with metastatic colorectal cancerFlorian Moik, Florian Posch, Ella Grilz, et al.Hamostaseologie|June 9, 2026
Risk Factors, Biomarkers, and Risk Assessment Models for Prediction of Venous Thromboembolism in Ambulatory Patients with Advanced Lung CancerLeyla Ay, Florian Moik, Thorsten Füreder, et al.European Journal of Clinical Investigation|July 24, 2026
Systemic Inflammation and Risk of Thromboembolism, Mortality, and Treatment Response in Patients With Cancer Receiving Immune Checkpoint InhibitorsLeyla Ay, Ingrid Pabinger, Matthias Preusser, et al.Pageof 6